Effects of synbiotics to prevent postoperative infectious complications in highly invasive abdominal surgery

Annals of Nutrition and Metabolism

Volumn 71, Issue 1, 2017, Pages 23-30

  Yokoyama, Yukihiro ^a   Asahara, Takashi ^b   Nomoto, Koji ^b   Nagino, Masato ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b YAKULT CENTRAL INSTITUTE FOR MICROBIOLOGICAL RESEARCH   (Japan)

Author keywords

Bacteremia; Bacterial translocation; Ribosomal RNA targeted RT PCR; Synbiotics

Indexed keywords

SYNBIOTIC AGENT;

ABDOMINAL SURGERY; BACTERIAL TRANSLOCATION; HUMAN; INFECTION PREVENTION; INVASIVE PROCEDURE; MICROENVIRONMENT; NONHUMAN; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; REVIEW; SURGICAL INFECTION;

DIGESTIVE SYSTEM SURGICAL PROCEDURES; HUMANS; SURGICAL WOUND INFECTION; SYNBIOTICS;

EID: 85030267215     PISSN: 02506807     EISSN: 14219697     Source Type: Journal    
DOI: 10.1159/000479920     Document Type: Review

References (28)

1. Kanazawa H, Nagino M, Kamiya S, Komatsu S, Mayumi T, Takagi K, et al: Synbiotics reduce postoperative infectious complications: A randomized controlled trial in biliary cancer patients undergoing hepatectomy. Langenbecks Arch Surg 2005; 390: 104-113.
2. Sugawara G, Nagino M, Nishio H, Ebata T, Takagi K, Asahara T, et al: Perioperative synbiotic treatment to prevent postoperative infectious complications in biliary cancer surgery: A randomized controlled trial. Ann Surg 2006; 244: 706-714.
3. Mizuno T, Yokoyama Y, Nishio H, Ebata T, Sugawara G, Asahara T, et al: Intraoperative bacterial translocation detected by bacterium-specific ribosomal Rna-targeted reverse-transcriptase polymerase chain reaction for the mesenteric lymph node strongly predicts postoperative infectious complications after major hepatectomy for biliary malignancies. Ann Surg 2010; 252: 1013-1019.
4. Nishigaki E, Abe T, Yokoyama Y, Fukaya M, Asahara T, Nomoto K, et al: The detection of intraoperative bacterial translocation in the mesenteric lymph nodes is useful in predicting patients at high risk for postoperative infectious complications after esophagectomy. Ann Surg 2014; 259: 477-484.
5. Yamaguchi N, Yokoyama Y, Ebata T, Igami T, Sugawara G, Asahara T, et al: Intermittent Pringle maneuver is unlikely to induce bacterial translocation to the portal vein: A study using bacterium-specific ribosomal RNA-targeted reverse transcription-polymerase chain reaction. J Hepatobiliary Pancreat Sci 2015; 22: 491-497.
6. Yokoyama Y, Mizuno T, Sugawara G, Asahara T, Nomoto K, Igami T, et al: Profile of preoperative fecal organic acids closely predicts the incidence of postoperative infectious complications after major hepatectomy with extrahepatic bile duct resection: Importance of fecal acetic acid plus butyric acid minus lactic acid gap. Surgery 2017;pii: S0039-6060(17)30329-X.
7. Tanaka K, Yano M, Motoori M, Kishi K, Miyashiro I, Ohue M, et al: Impact of perioperative administration of synbiotics in patients with esophageal cancer undergoing esophagectomy: A prospective randomized controlled trial. Surgery 2012; 152: 832-842.
8. Kimura I, Inoue D, Maeda T, Hara T, Ichimura A, Miyauchi S, et al: Short-chain fatty acids and ketones directly regulate sympathetic nervous system via G protein-coupled receptor 41 (GPR41). Proc Natl Acad Sci U S A 2011; 108: 8030-8035.
9. Ichimura A, Hirasawa A, Poulain-Godefroy O, Bonnefond A, Hara T, Yengo L, et al: Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human. Nature 2012; 483: 350-354.
10. Fukuda S, Toh H, Hase K, Oshima K, Nakanishi Y, Yoshimura K, et al: Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature 2011; 469: 543-547.
11. Canani RB, Costanzo MD, Leone L, Pedata M, Meli R, Calignano A: Potential beneficial effects of butyrate in intestinal and extraintestinal diseases. World J Gastroenterol 2011; 17: 1519-1528.
12. Yadav H, Lee JH, Lloyd J, Walter P, Rane SG: Beneficial metabolic effects of a probiotic via butyrate-induced GLP-1 hormone secretion. J Biol Chem 201330; 288: 25088-25097.
13. Furusawa Y, Obata Y, Fukuda S, Endo TA, Nakato G, Takahashi D, et al: Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 2013; 504: 446-450.
14. Huang W, Guo HL, Deng X, Zhu TT, Xiong JF, Xu YH, et al: Short-chain fatty acids inhibit oxidative stress and inflammation in mesangial cells induced by high glucose and lipopolysaccharide. Exp Clin Endocrinol Diabetes 2017; 125: 98-105.
15. Endo H, Niioka M, Kobayashi N, Tanaka M, Watanabe T: Butyrate-producing probiotics reduce nonalcoholic fatty liver disease progression in rats: New insight into the probiotics for the gut-liver axis. PLoS One 2013; 8: E63388.
16. Alverdy JC, Laughlin RS, Wu L: Influence of the critically ill state on host-pathogen interactions within the intestine: Gut-derived sepsis redefined. Crit Care Med 2003; 31: 598-607.
17. Hayakawa M, Asahara T, Henzan N, Murakami H, Yamamoto H, Mukai N, et al: Dramatic changes of the gut flora immediately after severe and sudden insults. Dig Dis Sci 2011; 56: 2361-2365.
18. Takagi K, Nakao M, Ogura Y, Nabeshima T, Kunii A: Sensitive colorimetric assay of serum diamine oxidase. Clin Chim Acta 1994; 226: 67-75.
19. Usami M, Miyoshi M, Kanbara Y, Aoyama M, Sakaki H, Shuno K, et al: Effects of perioperative synbiotic treatment on infectious complications, intestinal integrity, and fecal flora and organic acids in hepatic surgery with or without cirrhosis. JPEN J Parenter Enteral Nutr 2011; 35: 317-328.
20. Matsuda K, Tsuji H, Asahara T, Kado Y, Nomoto K: Sensitive quantitative detection of commensal bacteria by rRNA-targeted reverse transcription-PCR. Appl Environ Microbiol 2007; 73: 32-39.
21. Matsuda K, Tsuji H, Asahara T, Matsumoto K, Takada T, Nomoto K: Establishment of an analytical system for the human fecal microbiota, based on reverse transcription-quantitative PCR targeting of multicopy rRNA molecules. Appl Environ Microbiol 2009; 75: 1961-1969.
22. Rayes N, Seehofer D, Hansen S, Boucsein K, Muller AR, Serke S, et al: Early enteral supply of lactobacillus and fiber versus selective bowel decontamination: A controlled trial in liver transplant recipients. Transplantation 2002; 74: 123-127.
23. Rayes N, Seehofer D, Theruvath T, Schiller RA, Langrehr JM, Jonas S, et al: Supply of preand probiotics reduces bacterial infection rates after liver transplantation-A randomized, double-blind trial. Am J Transplant 2005; 5: 125-130.
24. Eguchi S, Takatsuki M, Hidaka M, Soyama A, Ichikawa T, Kanematsu T: Perioperative synbiotic treatment to prevent infectious complications in patients after elective living donor liver transplantation: A prospective randomized study. Am J Surg 2011; 201: 498-502.
25. Rayes N, Pilarski T, Stockmann M, Bengmark S, Neuhaus P, Seehofer D: Effect of pre-and probiotics on liver regeneration after resection: A randomised, double-blind pilot study. Benef Microbes 2012; 3: 237-244.
26. Yokoyama Y, Nishigaki E, Abe T, Fukaya M, Asahara T, Nomoto K, et al: Randomized clinical trial of the effect of perioperative synbiotics versus no synbiotics on bacterial translocation after oesophagectomy. Br J Surg 2014; 101: 189-199.
27. Yokoyama Y, Miyake T, Kokuryo T, Asahara T, Nomoto K, Nagino M: Effect of perioperative synbiotic treatment on bacterial translocation and postoperative infectious complications after pancreatoduodenectomy. Dig Surg 2016; 33: 220-229.
28. Rayes N, Seehofer D, Theruvath T, Mogl M, Langrehr JM, Nussler NC, et al: Effect of enteral nutrition and synbiotics on bacterial infection rates after pylorus-preserving pancreatoduodenectomy: A randomized, doubleblind trial. Ann Surg 2007; 246: 36-41.